Vivos Inc (RDGL): Revenue
$68.4K
Year ended 2025-12-31
$99.1K
Trailing 12 months to 2026-06-30
+23.3%
3-year compound annual growth
+57.7%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $68.4K | +144.3% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $28.0K | +43.6% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $19.5K | -46.6% | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | $36.5K | +145.2% | 2024-03-18, From 2022-01-01 |
| 2021-12-31 | $14.9K | +112.7% | 2023-03-01, From 2021-01-01 |
| 2020-12-31 | $7.0K | -26.3% | 2022-03-07, From 2020-01-01 |
| 2019-12-31 | $9.5K | n/a | 2021-03-24, From 2019-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Vivos Inc (RDGL) | 2025-12-31 | $68.4K | +144.3% |
| Family Office of America, Inc. (FOFA) | 2025-12-31 | $221.8K | n/a |
| QTREX Quantum Ltd. (QTEX) | 2025-12-31 | $289.0K | n/a |
| Pulse Biosciences, Inc. (PLSE) | 2025-12-31 | $350.0K | n/a |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $622.5K | -84.1% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $704.0K | +63.7% |
| Flyte Aviation, Inc. (VJET) | 2025-12-31 | $819.0K | +95.0% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $1.02M | -64.7% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $1.12M | n/m |
Compare RDGL, FOFA, QTEX, PLSE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗